Physician profile
Jane De Grasse
NPI 1851372155
$1,521.39
in general payments reported to CMS, 2019-2025
17 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $202 · 2021: $88.37 · 2022: $89.50 · 2023: $94.55 · 2024: $380 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $735.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $286.61 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $205.06 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $199.79 | 2022-2025 | Miebo, Infuse, Vyzulta |
| Optos, INC. | $153.39 | 2020 | |
| Biotissue Holdings INC. | $143.63 | 2024 | |
| Glaukos Corporation | $110.87 | 2019 | |
| Lkc Technologies, INC. | $97.17 | 2025 | |
| Alcon Vision LLC | $71.25 | 2019-2025 | Precision7, Total30 |
| Allergan, INC. | $49.54 | 2019-2021 | |
| Abbvie INC. | $45.19 | 2022 | |
| Abb Con-Cise Optical Group LLC | $39.67 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $28.84 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $26.31 | 2024 | |
| Shire North American Group INC | $20.28 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $17.18 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $14.56 | 2021 | |
| Visioneering Technologies, INC. | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane De Grasse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.